E-LIB Suche - Ergebnisse für: Voronina, Daria V. - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:

Voronina, Daria V. ; Shcheblyakov, Dmitry V. ; Favorskaya, Irina A....
Viruses. 14 (2022) 11 - p. 2485 , 2022

Link: https://doi.org/10.3390/..

2

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:

Favorskaya, Irina A. ; Shcheblyakov, Dmitry V. ; Esmagambetov, Ilias B....
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

3

Safety and efficacy of an rAd26 and rAd5 vector-based heter..:

Logunov, Denis Y ; Dolzhikova, Inna V ; Shcheblyakov, Dmitry V...
The Lancet. 397 (2021) 10275 - p. 671-681 , 2021

Link: https://doi.org/10.1016/..

4

Development of Neutralizing Nanobodies to the Hemagglutinin..:

Voronina, Daria V. ; Shcheblyakov, Dmitry V. ; Esmagambetov, Ilias B....
Acta Naturae. 13 (2021) 4 - p. 33-41 , 2021

Link: https://doi.org/10.32607..

5

An open, non-randomised, phase 1/2 trial on the safety, tol..:

Tukhvatulin, Amir I. ; Dolzhikova, Inna V. ; Shcheblyakov, Dmitry V....
The Lancet Regional Health - Europe. 11 (2021) - p. 100241 , 2021

Link: https://doi.org/10.1016/..

6

Nanobodies Are Potential Therapeutic Agents for the Ebola V..:

Esmagambetov, Ilias B. ; Shcheblyakov, Dmitriy V. ; Egorova, Daria A....
Acta Naturae. 13 (2021) 4 - p. 53-63 , 2021

Link: https://doi.org/10.32607..

7

Development of the covalent antibody-DNA conjugates technol..:

Maerle, Artem V. ; Simonova, Maria A. ; Pivovarov, Victor D....
PLOS ONE. 14 (2019) 1 - p. e0209860 , 2019

Link: https://doi.org/10.1371/..

8

Immuno-PCR technology for detection of natural human antibo..:

Maerle, Artem V. ; Voronina, Daria V. ; Dobrochaeva, Kira L....
Glycoconjugate Journal. 34 (2017) 2 - p. 199-205 , 2017

Link: https://doi.org/10.1007/..

9

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:

Favorskaya, Irina A ; Shcheblyakov, Dmitry V ; Esmagambetov, Ilias B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907979/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Anticancer Nanotherapeutics in Clinical Trials: The Work be..:

Parodi, Alessandro ; Kolesova, Ekaterina P. ; Voronina, Maya V....
International Journal of Molecular Sciences. 23 (2022) 21 - p. 13368 , 2022

Link: https://doi.org/10.3390/..

11

Innovative approach to the rehabilitation of patients under..:

Kulikov, A. G ; Voronina, Daria D. ; Luppova, I. V.
Medical and Social Expert Evaluation and Rehabilitation. 19 (2016) 3 - p. 125-128 , 2016

Link: https://doi.org/10.18821..

12

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:

Daria V. Voronina ; Dmitry V. Shcheblyakov ; Irina A. Favorskaya...
Viral Immunology, Vaccines, and Antivirals. , 2022

Link: https://doi.org/10.3390/..

13

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 ..:

Irina A. Favorskaya ; Dmitry V. Shcheblyakov ; Ilias B. Esmagambetov...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.822159/full. , 2022

Link: https://doi.org/10.3389/..

14

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemaggl..:

Daria V. Voronina ; Dmitry V. Shcheblyakov ; Irina A. Favorskaya...
https://www.mdpi.com/1999-4915/14/11/2485. , 2022

Link: https://doi.org/10.3390/..

15

An open, non-randomised, phase 1/2 trial on the safety, tol..:

Amir I. Tukhvatulin ; Inna V. Dolzhikova ; Dmitry V. Shcheblyakov...
http://www.sciencedirect.com/science/article/pii/S2666776221002271. , 2021

Link: https://doi.org/10.1016/..

1-15

Mehr Literatur finden